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Objectives. The purpose of this prospective study was to exam-
ine the role of echocardiography in patients with Staphylococcus
aureus bacteremia (SAB).
Background. The reported incidence of infective endocarditis
(IE) among patients with SAB varies widely. Distinguishing
patients with uncomplicated bacteremia from those with IE is
therapeutically and prognostically important, but often difficult.
Methods. One hundred-three consecutive patients undergoing
both transthoracic (TTE) echocardiography and transesophageal
(TEE) echocardiography were prospectively evaluated. All pa-
tients presented with fever and >21 positive blood culture and were
followed up for 12 weeks.
Results. Although predisposing heart disease was present in 42
patients (41%), clinical evidence of infective endocarditis (IE) was
rare (7%). TTE revealed anatomic abnormalities in 33 patients,
but vegetations in only 7 (7%), and was considered indeterminate
in 19 (18%). TEE identified vegetations in 22 patients (aortic valve
in 5, mitral valve in 9, tricuspid valve in 4, catheter in 2 and
pacemaker in 2, abscesses in 2, valve perforation in 1 and new
severe regurgitation in 1; 26 total [25%]). Using Duke criteria for
the diagnosis of IE, definite IE was present in 26 patients (25%).
Clinical findings and predisposing heart disease did not distin-
guish between patients with and without IE. The sensitivity of TTE
for detecting IE was 32%, and the specificity was 100%. The
addition of TEE increased the sensitivity to 100%, but resulted in
one false positive result (specificity 99%). TEE detected evidence
of IE in 19% of patients with a negative TTE and 21% of patients
with an indeterminate TTE. At follow-up, cure of staphylococcal
infection occurred in a similar percentage of patients with and
without IE (77% and 75%, respectively). However, death due to
sepsis was significantly more likely among patients with IE (4 of
26 [15%]) than among those without IE (2 of 77 [3%]) (p 5 0.03).
Conclusions. Our results suggest that IE is common among
patients admitted to the hospital with SAB and is associated with
an increased risk of death due to sepsis. TEE is essential to
establish the diagnosis and to detect associated complications.
Therefore, the test should be considered part of the early evalua-
tion of patients with SAB.
(J Am Coll Cardiol 1997;30:1072–8)
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Staphylococcus aureus bacteremia (SAB) is a serious, common
condition often associated with infective endocarditis (IE).
The reported incidence of IE in patients with SAB varies
widely depending on the patient population and has been
reported to be 5% to 64% (1–11). Distinguishing patients with
uncomplicated SAB from those with IE is therapeutically and
prognostically important, but often difficult. The clinical diag-
nosis of IE traditionally relies on typical Oslerian findings that
are often absent, especially in the early stages of disease
(12–14). The difficulty in diagnosing IE in patients with staph-
ylococcemia has made the practice of short-course therapy
(#14 days) for the treatment of uncomplicated SAB contro-
versial (15), primarily because of the potential for relapse in
patients with inadequately treated IE. This concern under-
scores the importance of establishing an accurate diagnosis
early in the course of therapy of patients with SAB.
Transthoracic echocardiography (TTE) is often used to
evaluate patients with suspected IE; indeed, the latest diagnos-
tic criteria for IE rely heavily on the echocardiogram (16).
However, the sensitivity of TTE to detect vegetations, the most
common echocardiographic manifestation of IE, is only 40%
to 80% (17), and the clinical utility of the test will vary,
depending on the prevalence of disease in the group being
studied. Given the variable prevalence of IE and the modest
sensitivity of TTE, it is not surprising that the clinical utility of
echocardiography in patients with SAB has not been estab-
lished.
Transesophageal echocardiography (TEE) has been shown
to be superior to TTE for the diagnosis of IE (18–21),
especially to identify small vegetations (22), prosthetic valve
endocarditis (23) and paravalvular abscesses (24). We there-
fore hypothesized that TEE would be diagnostically and
prognostically useful in patients with SAB. To test this hypoth-
esis and to determine the relative diagnostic value of the two
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echocardiographic modalities compared with clinical variables
for detecting IE in patients with SAB, we prospectively evalu-
ated a cohort of 103 consecutive patients with SAB who
underwent both TTE and TEE.
Methods
Patient group. Between September 1, 1994 and January 1,
1996, 284 inpatients at Duke University Medical Center had
one or more blood cultures positive for S. aureus and clinical
evidence of infection. One hundred-nine patients were ex-
cluded for the following reasons: age ,18 years (n 5 26),
polymicrobic infection (n 5 30), neutropenia (white blood cell
count ,1.0 3 109/liter) (n 5 17), death before blood cultures
turning positive (n 5 16) or outpatient status (n 5 20). The
remaining 176 patients were eligible for the current study.
Seventy-two of these patients did not undergo TEE because of
refusal by either the patient or attending physician. One
additional patient was excluded because TTE was not per-
formed. Thus, 103 patients with one or more blood cultures
positive for S. aureus underwent both TTE and TEE to find
evidence of IE and are included in this analysis. Table 1
compares the demographic and clinical characteristics of the
study group with those of patients who were screened and
subsequently excluded from participation.
Each patient underwent a prospective clinical examination
at the time of presentation by one of the investigators (V.G.F.,
K.A.M., A.K.G.) for signs suggestive of IE (new or changing
heart murmur, peripheral stigmata or splenomegaly) and focus
of infection. A lesion was considered the source (primary
focus) of infection if its presence antedated the bacteremia; all
other infections were considered secondary foci. An intravas-
cular catheter was considered as the portal of entry if 1) there
was evidence of inflammation at the catheter insertion site or
2) a catheter-tip culture was positive for S. aureus, or both, and
3) there was no evidence of an alternative source (25).
Staphylococcus aureus bacteremia was defined as community
acquired if positive blood cultures were obtained within 72 h of
hospital admission and nosocomial if the first positive blood
culture was obtained .72 h after hospital admission.
Definition of IE. Endocarditis was defined according to the
Duke criteria (16), a sensitive (16,26–30) and specific (26,31)
scheme relying on several criteria, designated major and
minor, to establish the diagnosis of IE (Table 2). Major criteria
include blood cultures persistently positive for typical endocar-
dial pathogens and echocardiographic evidence of IE such as
an intracardiac oscillating mass, abscess, new valvular regurgi-
tation or new dehiscence of a prosthetic valve.
Patient outcome. All patients were followed up 12 weeks
after the date of the first blood culture by telephone contact
with the patient, a family member or the patient’s primary care
physician. Four categories of outcome were defined: 1) cure—
patients in this category completed therapy for SAB and had
no recurrent staphylococcal infection within the 12-week
follow-up period; 2) relapse—patients in this category com-
pleted therapy for SAB and demonstrated clinical resolution of
their infection but had culture-confirmed recurrent S. aureus
infection with the same antibiogram as the initial isolate within
the follow-up period; 3) death due to SAB—patient deaths
were attributed to staphylococcal infection if the patient had
persistent signs or symptoms of infection, positive blood cul-
tures or a persistent focus of infection in the absence of
Abbreviations and Acronyms
IE 5 infective endocarditis
SAB 5 Staphylococcus aureus bacteremia
TTE 5 transthoracic echocardiography
TEE 5 transesophageal echocardiography
Table 1. Clinical and Demographic Characteristics of Patients With Staphylococcus aureus Bacteremia











Age (yr) 56 6 15 60 6 15 56 6 16 54 6 17
Gender (male) 57 (55%) 18 (69%) 39 (51%) 51 (47%)
Race
White 49 (48%) 10 (38%) 39 (51%) 58 (56%)
Black 50 (48%) 15 (58%) 35 (45%) 45 (41%)
Source of infection
No focus or unknown 6 (6%) 3 (12%) 3 (4%) 35 (32%)
Deep tissue infection 28 (27%) 7 (27%) 21 (27%) 35 (32%)
Catheter focus 69 (67%) 16 (61%) 53 (69%) 40 (37%)
Nosocomial 61 (59%) 17 (65%) 44 (57%) 68 (62%)
Community acquired 38 (37%) 8 (31%) 30 (39%) 36 (33%)
Acquired in nursing home 4 (4%) 1 (4%) 3 (4%) 4 (4%)
No comparison between patients with and without infective endocarditis reached statistical significance. Data are
presented as mean value 6 SD or number (%) of patients. IE 5 infective endocarditis; Pts 5 patients.
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another explanation for death; and 4) death due to underlying
disease—patients were placed in this category if deaths were
from defined underlying disease other than staphylococcal
bacteremia.
Echocardiography. TTE was performed using a 2.5- or
3.5-MHz phased-array transducer. Two-dimensional imaging
from multiple tomographic planes and spectral Doppler and
color flow imaging were used in all patients. TEE using a 5.0-
or 6.2-MHz transducer was performed in fasting patients, using
topical pharyngeal anesthesia and conscious sedation. Images
were recorded on 1⁄2-in. superVHS videotape and in a digital
full-screen cine loop display format (EchoNet, Heartlab, Inc.).
All echocardiograms were performed within 9 days of study
entry, and the results of all echocardiographic studies were
made available to the referring physicians. Informed consent
was obtained in all patients before TEE.
Echocardiograms were analyzed specifically for evidence of
IE. Findings consistent with IE included vegetations, ab-
scesses, paravalvular prosthetic valve regurgitation, new valvu-
lar regurgitation and otherwise unexplained valvular dysfunc-
tion (see later). Vegetations were defined as irregularly shaped
echogenic masses adherent to valves, endothelial surfaces or
intracardiac prosthetic devices (such as indwelling catheters or
pacemaker leads). From the TEE recording, vegetations were
categorized as either small (#8 mm in greatest dimension) or
large (.8 mm in dimension). Variables used to differentiate
vegetations from noninfectious masses included oscillating
motion (high frequency movement independent of the associ-
ated valvular motion), mobility (exceeding and independent of
the associated valve structure) and shaggy or irregular surfaces.
Because serial studies were not analyzed, a change in appear-
ance or size over time was not a diagnostic criterion used in
this study. Abscesses were defined as thickened areas or
masses within the myocardium or annular region, character-
ized by an irregular nonhomogeneous echogenic or echolucent
appearance. Blood flow within the space, as defined using color
Doppler imaging, was an additional variable used to support
the diagnosis of an abscess. Other unexplained valvular
abnormalities believed to be consistent with IE included new
valvular regurgitation (at least moderate in severity, not dem-
onstrated on a previous echocardiogram) or valvular tissue
destruction or perforation (detected with a combination of
typical findings on two-dimensional echocardiographic and
color flow imaging.)
Echocardiograms were also analyzed for the presence or
absence of heart disease predisposing to IE. Factors thought to
increase the risk of susceptibility included nonspecific abnor-
malities (such as leaflet thickening, prolapse, calcification or
regurgitation), congenital heart disease (except uncomplicated
secundum atrial septal defect) and the presence of intracardiac
devices (including prosthetic valves, indwelling catheters or
pacemaker leads).
TTE results were categorized as either diagnostic of IE,
negative or indeterminate. A study was considered diagnostic
of IE if any one of the echocardiographic criteria described
previously was present. The TTE was considered negative if
image quality was adequate to permit evaluation of all four
valves and none of the diagnostic echocardiographic criteria
listed above were fulfilled. An indeterminate result included 1)
the presence of predisposing heart disease, not meeting diag-
nostic echocardiographic criteria for IE; 2) other structural or
functional valvular abnormalities not meeting the previous
criteria for a firm diagnosis of IE; or 3) inadequate image
quality precluding complete evaluation.
TEE results were analyzed in a similar fashion, using
identical criteria to establish the diagnosis of IE. Because TEE
is often used as the final arbiter to judge the presence or
absence of IE in patients with bacteremia, we attempted to
categorize the TEE result as either positive or negative. Thus,
an indeterminate result was not permitted in the interpretation
of the TEE.
An attending echocardiographer did a clinical reading of all
echocardiograms at the time of the procedure. In the majority
Table 2. Summary of Duke Criteria for Infective Endocarditis
I. Major criteria
A. Positive blood cultures for IE
1. Typical organisms from two or more separate blood cultures
a. Streptococcus viridans,* Streptococcus bovis, HACEK group or
b. Community-acquired Staphylococcus aureus or enterococci, in the
absence of a primary focus, or
2. Persistently positive blood culture, defined as recovery of a
microorganism consistent with IE from
a. Blood cultures drawn .12 h apart or
b. All of three or a majority of four or more separate blood cultures,
with first and last drawn at least 1 h apart
B. Evidence of endocardial involvement
1. Echocardiogram positive for IE
a. Oscillating intracardiac mass on valve or supporting structure, or in
the path of regurgitant jets or on implanted material, in the absence
of an alternative anatomic explanation or
b. Abscess or
c. New partial dehiscence of a prosthetic valve or
2. New valvular regurgitation (increase or change in preexisting murmur
not sufficient)
II. Minor criteria




E. Microbiologic evidence: positive blood culture not meeting major
criterion† or serologic evidence of active infection with appropriate
organism
F. Echocardiogram consistent with IE but not meeting major criterion
III. Definite IE defined using:
A. Pathologic criteria
1. Microorganism demonstrated by culture or histologic study in a
vegetation, a vegetation that has embolized or in an intracardiac
abscess or
2. Pathologic lesions confirmed by histologic study showing active IE
B. Clinical criteria (see above): two major or one major and three minor or
five minor
*Including nutritional variant strains. †Excluding single positive cultures for
organisms that do not cause infective echocarditis (IE). HACEK 5 Haemophilus
aphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis,
Eikenella corrodens, Kingella kingae.
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of cases, the TEE was performed after the TTE. Because of the
potential bias created by sequential readings, all TEEs were
later reinterpreted in a blinded manner by one of the investi-
gators. To minimize the bias created by knowing that all
patients in the series had SAB, 20 randomly selected TEEs
were mixed into the case series being reviewed. This was
designed to reduce the pretest likelihood of disease in the
series of echocardiograms being interpreted in blinded man-
ner. None of the 20 randomly selected TEEs were read as
having IE. Agreement between the clinical and investigator
interpretations was excellent (100 of 103 [97%]). In all three
discordant results, the clinical reading was negative, whereas
the blinded reading was positive for IE. The results of the
clinical interpretation were used for all subsequent data anal-
yses.
Statistics. For continuous variables, data are expressed as
the mean value 6 SD unless otherwise specified. Categoric
variables are expressed as a percentage. For categoric vari-
ables, comparisons between groups were made using the
chi-square test. Results were considered significant at p , 0.05.
Results
Demographics and clinical features. Between September
1, 1994 and January 27, 1996, 103 (59%) of 176 eligible patients
with SAB were prospectively examined by TTE and TEE
within 5.7 6 3.4 days of the first positive blood culture. Of
these 103 patients, 18 (17%) had one blood culture positive
and 85 (83%) had more than one blood culture positive for
SAB. All 26 patients with definite IE had more than one
positive blood culture. The mean interval between TTE and
TEE was 2.5 6 4.0 days. The demographic and clinical features
of the patients with and without IE are presented in Table 1.
The mean age of the patients was 56 6 15 years. Fifty patients
(49%) were African-American, 49 (48%) were white, and 57
(55%) were men. Injection drug use was a predisposing factor
in 12 patients (12%). An identifiable source of bacteremia was
present in 97 patients (94%)—an intravascular device in 69
patients and a deep tissue infection in 28 patients. Six of the
patients were injection drug users with no obvious focus of
infection. Community- or nursing home–acquired SAB oc-
curred in 42 patients, and nosocomial SAB occurred in the
remaining 61 patients.
Clinical evidence of IE. Forty-two patients (41%) had
either clinical or echocardiographic evidence, or both, of
predisposing heart disease (Table 3). A prosthetic valve was
present in 5 patients; 4 patients had pacemakers; and 33 had
valvular abnormalities, including 16 patients with moderate or
severe valvular regurgitation and 17 with thickened or calcified
leaflets, or both.
Clinical evidence of IE was rare, occurring in only 7 (7%) of
103 patients. Of these seven patients, five had peripheral
emboli and two developed new murmurs. Five (71%) of these
seven patients met Duke criteria for definite IE. No patient
demonstrated autoimmune phenomena or splenomegaly. A
history of previous IE was present in four patients, all of whom
were injection drug users. Two of these patients met Duke
criteria for definite IE—one involving a native tricuspid valve
and the other a prosthetic mitral valve. Thus, neither predis-
posing heart disease nor clinical findings at the time of
presentation were useful variables to distinguish between
patients with and without IE (Table 3).
Echocardiographic findings. Echocardiographic findings
are summarized in Table 3. TTE revealed predisposing ana-
tomic abnormalities for IE, such as leaflet thickening or
calcification, or both, in 33 (32%) of 103 patients. Trans-
thoracic echocardiography was negative for IE in 77, indeter-
minate in 19 and positive for vegetations in 7 patients (Fig. 1).
These vegetations involved the mitral valve (n 5 2), aortic
valve (n 5 2) and tricuspid valve (n 5 3). Other findings
consistent with IE, such as abscess or leaflet perforation, were
not detected with TTE. TEE was significantly more sensitive
for detecting vegetations compared with TTE (p 5 0.004) and
identified vegetations in 22 patients (aortic valve in 5, mitral
valve in 9, tricuspid valve in 4, indwelling catheter in 2 and
pacemaker in 2), aortic root abscess in 2, valve perforation
(anterior leaflet) in 1 and new severe valvular regurgitation in
1 patient. Vegetations were small (#8 mm maximal dimen-
sion) in 15 patients (68%). Of the seven large vegetations (9- to
30-mm maximal dimension), four involved the tricuspid valve.
No vegetation seen on TTE was missed by TEE and no single
Table 3. Predisposing Factors and Clinical Features in Patients With






Intravenous drug use 5 7
Previous IE 2 3
Valvular abnormalities 12 21
Prosthetic valve 3 2
Pacemaker 2 2
Clinical features
New murmur 2 0
Embolic event 3 2
None of the differences between the groups with and without IE reached
statistical significance. IE 5 infective endocarditis; Pts 5 patients.
Figure 1. A comparison of the results of TTE (open bars) and TEE
(solid bars) in all 103 study patients. Although both tests identified the
same number of patients as negative, TEE identified significantly more
positive results (p 5 0.0005). In 19 patients, the results of TTE were
considered indeterminate for IE. By study design, TEE studies were
not interpreted as indeterminate.
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category of findings accounted for the increased diagnostic
yield provided by TEE (Table 4). Overall, TEE identified
evidence of IE in 26 patients compared with 7 patients in
whom TTE was used (p 5 0.0005).
A comparison of the results of the two echocardiographic
modalities is presented in Figure 2. Among 19 patients with an
indeterminate TTE result, vegetations were detected by TEE
in four patients, and the remaining 15 patients were reclassi-
fied as negative. Of the 77 patients with a negative TTE, 15 had
vegetations on TEE. Thus, TEE detected evidence of IE in 4
(21%) of 19 patients with an indeterminate TTE and 15 (19%)
of 77 patients with a negative TTE.
Diagnosis of IE. Twenty-six patients met Duke criteria for
definite IE. In all patients, two major criteria (echocardio-
graphic findings and persistently positive blood cultures) were
present. The diagnosis was based on TTE findings in only
seven patients. Thus, using Duke criteria, the sensitivity of
TTE to detect definite IE in this group was 32%. Although
there were no false positive TTE findings, the negative predic-
tive value of the test was only 81%, in part due to the number
of indeterminate TTE results (n 5 19). In 19 patients (73%),
the diagnosis was established on the basis of TEE findings
alone. No patient met Duke criteria for definite IE in the
absence of a positive TEE, resulting in a sensitivity of 100%.
The incremental yield provided by TEE was predominantly
due to its ability to detect small vegetations and intracardiac
complications such as abscesses. One patient was diagnosed
with IE despite the absence of vegetations on TEE, on the
basis of new severe aortic regurgitation and persistently posi-
tive blood cultures. This patient, who was later found to have
an aortic root dissection but no pathologic evidence of IE, was
classified as having a false positive result, yielding a specificity
of 99%.
Patient outcome. All patients were followed up for 12
weeks after the first positive blood culture. Clinical outcome at
the time of follow-up is summarized in Table 5. Staphylococcal
infection was cured with similar frequency in both groups (77%
in patients with IE and 75% in patients without IE, p 5 NS).
Death due to staphylococcal sepsis was significantly more likely
in patients with IE (4 [15%] of 26) than in those without IE (2
[1.3%] of 77, p 5 0.003). None of the 77 patients in whom the
diagnosis of IE was excluded on the basis of the Duke criteria
and a negative TEE subsequently developed IE, although 9
had a relapse due to deep tissue infections. Treatment failure
occurred in 5 (19%) of 26 patients with IE and 11 (13%) of 77
patients without IE (p 5 NS).
Discussion
Comparison with previous studies. Staphylococcus aureus
is the second most common cause of native valve endocarditis
(32,33) and is associated with a high mortality (34–36). A
continuing challenge has been the prospective identification of
IE in patients with staphylococcemia. Both clinical and echo-
cardiographic criteria have been suggested as means to estab-
lish a diagnosis. In their classic 1976 study, Nolan and Beaty
(8), reporting on 105 retrospectively collected patients with
SAB, found that S. aureus IE may be predicted by the clinical
triad of 1) community acquisition; 2) absence of an obvious
primary focus; and 3) evidence of metastatic foci. Our results
contrast sharply with their observations. There are several
possible explanations to account for this difference:
1. The majority of our patients with definite IE (65%)
acquired endocarditis while in the hospital. This is in contrast
to the only other large prospective series, in which IE was
detected in only 2 of 114 consecutive episodes of SAB (6).










New valvular regurgitation 0 1
Total 7 26†
*p 5 0.004, †p 5 0.0005 versus transthoracic echocardiography (TTE).
TEE 5 transesophageal echocardiography.
Figure 2. TEE results are shown as a function of the TTE findings,
demonstrating the incremental value of TEE. Among 77 patients with
a negative TTE result, 15 had evidence of IE on TEE. Among 19
patients with an indeterminate TTE result, 15 were reclassified as
negative and 4 as positive by TEE. All seven patients with a positive
TTE also had a positive TEE.






Resolution of infection 20 58
Relapse 1 9
Death due to SAB 4 2*
Death due to other causes† 1 8
*p 5 0.003 versus infective endocarditis. †Other causes include malignancy
(n 5 3), myocardial infarction (n 5 2), infection with another organism,
pulmonary embolus (n 5 1) and toxic megacolon (n 5 1). IE 5 infective
endocarditis; SAB 5 Staphylococcus aureus bacteremia.
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Unfortunately, in that series, a uniform method of screening
for IE was not carried out and clinical variables were used to
guide the evaluation. As a result, underestimation of the
number of cases of IE is quite possible, as would have occurred
in our study had only clinical variables been used. In support of
this underdiagnosis was the high mortality (32%) of hospital-
acquired SAB reported in that clinical study (15), despite the
absence of apparent IE. Other evidence supporting the high
incidence of unsuspected IE among patients with staphylococ-
cemia comes from a Danish study of 118 patients with docu-
mented S. aureus IE (34). In a country where autopsies are
compulsory, 65 of these patients (55%) had no clinical evi-
dence of IE and were only diagnosed at autopsy.
2. A second difference between our results and that of
Nolan and Beaty (8) is that most patients with IE in our series
(88%) had a known focus of infection. There are several
possible reasons for this difference. The prospective design of
our registry mandated examination of each patient with SAB at
the time of presentation. Thus, sources of infection were
identified early in the course of therapy. The low number of
injection drug users and the high percentage of hospitalized
patients are additional features that distinguish the current
study from that of Nolan and Beaty (8).
3. Metastatic foci of infection were much less common in
our experience. This may be due to the brief interval between
the onset of symptoms and the initiation of antibiotic therapy
in our patients (mean interval 2.4 days), thus aborting subse-
quent metastatic complications (37).
Detecting IE among patients with SAB. Thus, the tradi-
tional clinical predictors of IE in patients with SAB were of
minimal value in establishing a diagnosis. In addition, the
clinical examination itself provided evidence of IE in ,20% of
patients. It is therefore apparent that other methods are
needed to aid in the diagnosis of IE among patients with SAB.
We postulated that echocardiography, because it is an integral
element of the Duke criteria, would be useful for this purpose.
This application of echocardiography has not been tested in
any previous prospective series. We therefore elected to
perform both TTE and TEE early in the course of therapy of
patients with SAB. The consistent prospective implementation
of TEE appears to be the most important factor in differenti-
ating our study from previous ones. We found that TEE
detected evidence of clinically unsuspected IE in a high
percentage of patients with SAB and was more sensitive than
either clinical findings or TTE for this purpose. Intracardiac
complications such as abscess and valve perforation were only
detected by TEE.
In an attempt to define a subset of patients in whom TEE
would be most beneficial, we evaluated its incremental value in
patients with indeterminate as well as normal transthoracic
studies (Fig. 2). In contrast to previous reports in which the
diagnostic yield of TEE among patients with a normal TTE is
very low (38), our findings in patients with SAB suggest
otherwise. In fact, TEE evidence of IE was equally likely
among patients with negative compared with indeterminate
TTE results (both ;20%). Performing TEE only in patients
with an indeterminate TTE result would have led to a failure
to diagnose IE in 15 patients with “normal” transthoracic
studies. Thus, the incremental yield of TEE cannot be pre-
dicted on the basis of the TTE results. Indeed, from our
results, it would appear impossible to define a subset of
patients with SAB in which TEE should not be performed.
The increase in diagnostic yield provided by TEE compared
with TTE is higher in the present study than in previously
reported series of patients with IE (39). The most likely
explanation for this finding relates to the study design, which
promoted the use of echocardiography early in the course of
bacteremia, often before IE was clinically suspected. As a
result, most echocardiograms were obtained at an early stage
of disease, when vegetations were smaller and complications
less likely. These conditions would tend to maximize the
diagnostic superiority of TEE. Support for this argument lies in
our observation that most of the vegetations (11 of 16)
detected only by TEE were small in size.
Study limitations. There are several limitations to our
investigation. First, only 59% of eligible adult inpatients with
SAB during the period of data collection underwent both TTE
and TEE. Our study design was susceptible to sampling bias
because physicians tended to refer patients who had a greater
likelihood of IE for echocardiography. However, because over
one-third of our study patients had “low risk” (6,40,41)
catheter-related bacteremia and were undergoing echocardi-
ography to support short-course antibiotic therapy, this sam-
pling bias was minimized. Furthermore, even if all patients who
did not undergo TEE had IE, 26 (15%) of the 174 total
patients would still have definite IE.
Finally, the diagnosis of definite IE in our study was largely
based on echocardiographic rather than pathologic features.
According to the Duke criteria, the finding of a vegetation in a
patient with persistent SAB would establish the diagnosis of IE
by fulfilling two major criteria. In some cases, especially in the
presence of a “small” vegetation, false positive results may
occur. This would lead to overtreatment of some patients with
uncomplicated bacteremia who are mislabelled as having IE.
Alternatively, this group may represent a form of “early” IE
that may be cured with short-course therapy. Although speci-
ficity is difficult to address in studies such as ours, previous
investigators have confirmed the high specificity of the Duke
criteria in other patient groups (31). The fact that 15% of all
study patients with definite IE died from staphylococcemia,
whereas ,3% of the remaining patients died as a result of
sepsis, suggests that the diagnosis of IE was correct in the
majority of cases.
Conclusions. To our knowledge, this is the first prospective
series to use TEE to evaluate patients with SAB and the first
to compare TEE with TTE in patients with staphylococcemia.
Our findings suggest that IE is common among patients with
SAB and is associated with an increased risk of death from
sepsis. Establishing the diagnosis of IE in these patients is
often difficult. The results of the current study suggest that
TEE is frequently needed to secure a diagnosis and to detect
serious intracardiac complications. Therefore, the test should
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be strongly considered in patients with SAB and may be of
particular value early in the course of therapy. Further evalu-
ation of patients with small vegetations seen only on TEE, as
well as their response to short-course therapy, will help guide
the use of this sensitive technology in the future.
We acknowledge Allen Hsieh, MD for assistance with statistical analysis.
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